Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Genscript Biotech Corp (OP: GNNSF )

1.605 UNCHANGED
Streaming Delayed Price Updated: 1:34 PM EDT, Jul 31, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2
Open 1.605
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 1.605
Today's Range 1.605 - 1.605
52wk Range 1.050 - 3.200
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Will Genscript Cash Out Of Legend Biotech In The Face Of Fat Profit Temptation?
Key Takeaways: Analysts expect annual sales of Carvykti, Legend Biotech’s core cancer therapy, to peak at $7.3 billion With about $2 billion in cash reserves, Genscript isn’t under pressure to sell its... 
Via Benzinga
Week In Review: Korea's SK Biopharma Acquires Radiopharmaceutical In $571 Million Deal
In recent news, South Korea’s SK Biopharma in-licensed global rights to a radiopharmaceutical compound developed by Full-Life Technologies of Shanghai in a $571 million deal. 
Via Talk Markets

Performance

YTD
-22.46%
-22.46%
1 Month
+0.31%
+0.31%
3 Month
+9.18%
+9.18%
6 Month
-11.33%
-11.33%
1 Year
-25.69%
-25.69%

More News

Read More
Week In Review: Structure Reports Efficacy Of Obesity Drug; Raises $476 Million
Via Talk Markets
3 DNA Stocks to Buy for the Synthetic Biology Revolution
Via InvestorPlace
The Next Big Disruptors? 3 Biotech Stocks Making Headlines.
Via InvestorPlace
Week In Review: Mabwell Out-Licenses Rare Disease Drug For $412.5 Million
Via Talk Markets
Three Pharma Stocks to Sell Before They Die
Via InvestorPlace
Week In Review: Akeso Out-Licenses PD-1/VEGF To Summit In $5 Billion Pact
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.